Nurix Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 50k | 22.47 |
| 2024-06-30 | $572k | 27k | 20.87 |
| 2024-03-31 | $2.7M | 185k | 14.70 |
| 2023-12-31 | $157k | 15k | 10.33 |
| 2023-09-30 | $332k | 42k | 7.88 |
| 2023-03-31 | $1.0M | 113k | 8.88 |
| 2022-12-31 | $808k | 74k | 10.98 |
| 2022-09-30 | $1.6M | 121k | 13.03 |
| 2021-12-31 | $2.2M | 77k | 28.95 |
| 2021-03-31 | $2.6M | 85k | 31.09 |
| 2020-12-31 | $116k | 3.5k | 33.01 |
| 2020-09-30 | $19k | 533 | 35.65 |